Publications by authors named "Steven M Schmid"

Claim this Profile
A
Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.
Cecile Rouleau, Diego A Gianolio, Robert Smale, Stephanie D Roth, Roy Krumbholz, Steven M Schmid

Mol Cancer Ther· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.
Diego A Gianolio, Cecile Rouleau, William E Bauta, Dennis Lovett, William R Cantrell, Steven M Schmid

Cancer Chemother Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genz-644282, a novel non-camptothecin topoisomerase I inhibitor for cancer treatment.
Leslie S Kurtzberg, Stephanie Roth, Roy Krumbholz, Jennifer Crawford, Christy Bormann, Steven M Schmid

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents.
Leslie S Kurtzberg, Stephanie D Roth, Rebecca G Bagley, Cecile Rouleau, Min Yao, Steven M Schmid

Cancer Chemother Pharmacol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanism of action of docetaxel (Taxotere) in xenograft models is not limited to bcl-2 phosphorylation.
Lisa Ann Kraus, Shanti K Samuel, Steven M Schmid, Donald J Dykes, William R Waud

Invest New Drugs· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis